Lipid-regulating drugs

Statins reduce cardiovascular risk in patients who experience adverse reactions

A study in the Annals of Internal Medicine suggests that continuing statin treatment beyond the first two years can be beneficial.…

People in their 20s and 30s should be offered statins, researchers say

Scientists at Imperial College London suggest that people in their 20s and 30s should be offered statins.…

Genetic variant predisposes individuals to statin- and non statin-related muscle pain

A study has identified a common genetic variant of the LILRB5 gene that predisposes people to developing muscle aches regardless of whether they have been taking a statin…

Statins could protect against breast cancer

Being diagnosed with hyperlipidaemia could protect you against breast cancer and early mortality, according to research presented at the European Society of Cardiology Congress 2017.…

Discontinuing statins after stroke increases risk of another

Stopping statin therapy after ischaemic stroke should be discouraged to avoid increased risk of another stroke.…

NICE guidance could see 12 million adults prescribed statins in England, researchers say

Almost 12 million adults in England would be recommended statins if NICE guidance on cardiovascular disease risk and lipid-lowering treatment was applied to the population, researchers say…

NICE recommends statins should be offered to everyone with chronic kidney disease

Healthcare professionals should offer statins to the millions of people who have chronic kidney disease to help manage their increased risk of cardiovascular disease, NICE has urged…

Statins linked to improved heart structure and function

A large study using data from the UK Biobank found that people taking statins were less likely to have thickening of the heart muscle and enlarged heart chambers.…

US researchers say statins may speed up Parkinson’s in susceptible patients

A new study suggests that the use of statins is associated with a higher risk of developing symptoms of Parkinson’s disease.…

Phase III trial will investigate potential of statins as treatment for multiple sclerosis

The potential of the cheap cholesterol-lowering drug simvastatin as a treatment option for multiple sclerosis is to be investigated in a phase III trial involving more than 1,000 patients.…